Can inflammatory signaling disrupt insulin-receptor pathways and reduce cellular glucose uptake?

Inflammation and impaired insulin action are biologically connected, particularly in skeletal muscle and adipose tissue, where insulin-dependent glucose disposal relies on intact intracellular signaling and GLUT4 trafficking.

Mechanistic evidence

• Insulin signaling normally proceeds from the insulin receptor through IRS-1, PI3K, and Akt, culminating in translocation of GLUT4 transporters to the cell surface. Surface GLUT4 enables glucose entry into insulin-responsive muscle and adipose cells.
• Disruption of this IRS-1–PI3K–Akt pathway reliably reduces GLUT4 translocation and therefore insulin-stimulated cellular glucose uptake.
• TNF-α and related inflammatory signals can activate JNK and IKKβ/NF-κB-associated kinase pathways. These kinases can increase inhibitory serine/threonine phosphorylation of IRS-1, weakening signaling from the insulin receptor to PI3K–Akt and plausibly reducing GLUT4-mediated glucose uptake.

Human relevance and context

• In older men, higher circulating IL-6 was independently associated with lower insulin-mediated glucose disposal measured by euglycemic clamp, including among normal-weight men without diabetes or metabolic syndrome. This is consistent with chronic inflammatory burden accompanying reduced insulin sensitivity.
• Cytokine effects depend on timing and physiological context. Acute IL-6 infusion increased glucose disposal by approximately 15% in healthy participants, so acute IL-6 actions should not be interpreted as equivalent to chronic inflammatory signaling.

Clinical interpretation

• The downstream relationship—impaired insulin-receptor signaling leading to reduced glucose uptake—is well established.
• Inflammatory kinase activation provides a credible molecular route to this impairment, although the full causal sequence is most directly demonstrated in cellular and animal models rather than human insulin-responsive tissue.

Bottom line

• Inflammatory signaling can plausibly impair IRS-1–PI3K–Akt insulin signaling and thereby reduce GLUT4-dependent cellular glucose uptake; the insulin-signaling-to-glucose-uptake link is strongly supported, while human evidence supports an important association between chronic inflammation and insulin resistance.